CDKN2A and melanoma: However, compared to CDKN2A mutations, which account for about 40 percent of familial atypical multiple mole–melanoma (FAMMM) syndrome and 2 percent of all melanoma cases, these subsequently discovered melanoma-predisposing mutations are relatively rare, comprising less than 1 percent of hereditary melanoma [4,26].